It's hard to see an immediate catalyst for MAKO at the moment. Its surgical robotics are undoubtedly groundbreaking, but there's more competition these days, and system issues and product recalls don't instill confidence. Even at its current discount, I can't recommend the stock, but let me know in the comments section below if you think MAKO Surgical can get its bearings again and rise to the occasion.